Description |
ephrin B2 |
EPH receptor B4 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Dasatinib
- N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
- N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE
- N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE
- 3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide
- N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine
- N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE
- N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE
- 3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE
- Tesevatinib
- Fostamatinib
|
Diseases |
|
|
GWAS |
- BMI x environmental factors (excluding physical activity) interaction ( 33654129)
- BMI x environmental factors (including physical activity) interaction ( 33654129)
- Left superior temporal gyrus thickness (schizophrenia interaction) ( 26249676)
- Metabolite levels ( 23823483)
- Pediatric autoimmune diseases ( 26301688)
- Subcutaneous adipose tissue ( 26480920)
|
|
Interacting Genes |
23 interacting genes:
ANKRD46
DLG4
EPHA3
EPHA4
EPHB1
EPHB2
EPHB4
EPHB6
GRIP1
GRM1
GRM5
HOMER1
NCK2
PDZRN3
PECAM1
PICK1
PSEN1
PTPN13
RELN
RGS3
RHBDL2
SDCBP
SRC
|
9 interacting genes:
APP
CLDN3
DNAJB6
EFNB2
EMILIN1
FBXO7
GRIN1
MAP3K4
SDC3
|
Entrez ID |
1948 |
2050 |
HPRD ID |
02754 |
02481 |
Ensembl ID |
ENSG00000125266
|
ENSG00000196411
|
Uniprot IDs |
P52799
|
P54760
Q541P7
Q96L35
|
PDB IDs |
2HLE
2I85
2VSK
2VSM
2WO2
3GXU
4UF7
6P7Y
6PDL
|
2BBA
2E7H
2HLE
2QKQ
2VWU
2VWV
2VWW
2VWX
2VWY
2VWZ
2VX0
2VX1
2X9F
2XVD
2YN8
3ZEW
4AW5
4BB4
6FNI
6FNJ
6FNK
6FNL
6FNM
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|